Loading organizations...
§ Private Profile · San Francisco, CA, USA
PAX Labs is a technology company.
PAX Labs has raised $492.7M across 3 funding rounds.
Key people at PAX Labs.
PAX Labs has raised $492.7M in total across 3 funding rounds.
PAX Labs develops and manufactures advanced vaporization technology for cannabis, offering a range of sleek, portable devices for both dry herb and cannabis concentrates, alongside proprietary oil vape pens. The company’s core technical approach emphasizes precise temperature control and efficient material usage, ensuring consistent potency and flavor. PAX also expands its product portfolio to include high-purity THC edibles, enhancing its commitment to diverse cannabis consumption experiences.
The company was founded in 2007 by James Monsees and Adam Bowen, both graduates of Stanford University's design program, initially operating under the name Ploom. Their foundational insight stemmed from a desire to apply sophisticated design and engineering principles to create elegant, user-friendly alternatives for consuming plant-based materials, moving beyond traditional methods. This vision led to the development of their signature vaporization devices, combining form with function.
PAX Labs caters to adult consumers who prioritize quality, discretion, and a refined experience in their cannabis consumption. The company's long-term vision centers on elevating the perception and accessibility of cannabis through continuous innovation, superior product design, and a deep understanding of consumer needs. It aims to deliver exceptional and consistent experiences, driven by a genuine passion for the plant and its potential.
PAX Labs is a San Francisco-based cannabis technology company that designs and sells premium vaporizers, cannabis-infused pods, gummies, and accessories, emphasizing clean, controlled consumption experiences through advanced engineering.[1][2][6] Founded in 2007, it has raised $617 million in funding with a $1.7 billion valuation as of 2019, serving global consumers in legalized markets by solving safety, purity, and flavor issues in cannabis vaping and edibles.[1][3] Its products—like PAX Plus, PAX Mini, Era devices, live rosin pods, and THC gummies—target adult users seeking alternatives to smoking, with features such as patented heat-not-burn technology, precise temperature control, and rigorous contaminant testing.[2][5][6] The company has shown strong growth through product launches (e.g., Effects line like Sleep pods) and market expansion into Canada and California, positioning it as a leader in the booming vaporizer sector projected to grow at 25.6% CAGR through 2026.[3][5]
PAX Labs originated as Ploom in 2007, founded by James Monsees and Adam Bowen in San Francisco, initially aiming to create a cigarette alternative via vaporizer technology.[1][3] The idea emerged from a desire to innovate in consumer smoking experiences, leading to the 2012 launch of the Pax vaporizer, followed by iterative models like Pax 2 (2014), Pax 3 (2016), and Era pod system (2016).[2][3] A pivotal moment came in 2015 with the development of the Juul e-cigarette, which spun out as Juul Labs in 2017, allowing PAX to refocus on cannabis-specific devices.[2][3] Early traction built on engineering talent in the Bay Area, evolving from tobacco alternatives to cannabis vapes, pods, and edibles amid legalization trends, with headquarters providing access to regulatory and tech ecosystems.[1]
PAX Labs rides the global cannabis legalization wave and the shift to "heat-not-burn" vaporizers as healthier smoking alternatives, capitalizing on market forces like rising acceptance in the US, Canada, and beyond.[1][3] Timing aligns with post-2018 US farm bill expansions and international deployments, fueling a vape tech market with 25.6% CAGR potential through 2026 amid oversaturation in flower products—PAX differentiates via hardware-pod exclusivity and edibles.[3] It influences the ecosystem by setting standards in safety testing, app-integrated devices, and scientifically backed formulations (e.g., Sleep pods), inspiring competitors while expanding from vapes to gummies, and normalizing premium cannabis tech.[5][6]
PAX Labs is primed for aggressive scaling with next-gen devices, Effects line expansions (e.g., more form factors), international growth in CBD/cannabis markets, and deeper hardware-software integration.[1][5] Trends like sustained legalization, consumer demand for pure edibles/vapes, and AI-enhanced personalization will shape its path, potentially solidifying dominance in a fragmented space. Its influence may evolve from vaporizer pioneer to full-spectrum cannabis lifestyle brand, leveraging $1.7B valuation and innovation edge to capture share in a maturing industry—echoing its origin as a simple cigarette alternative now redefining premium consumption.[1][3]
Key people at PAX Labs.
PAX Labs has raised $492.7M across 3 funding rounds. Most recently, it raised $420.0M Other Equity in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 22, 2019 | $420M Venture Round | — | Anne Wojcicki, Prescott General Partners, TAO Capital Partners, Tiger Global | Announced |
| Oct 1, 2018 | $26M Series U | — | Frontier Ventures, LAUNCH, Long Journey Ventures, Tribe Capital, Alex Pattis | Announced |
| Jun 10, 2015 | $46.7M Series C | — | Fidelity Management & Research Company, Sand Hill Angels, Sivia Capital, TAO Capital Partners | Announced |
PAX Labs has raised $492.7M in total across 3 funding rounds.
PAX Labs's investors include Anne Wojcicki, Prescott General Partners, Tao Capital Partners, Tiger Global, Frontier Ventures, LAUNCH, Long Journey Ventures, Tribe Capital, Alex Pattis, Fidelity Management & Research Company, Sand Hill Angels, Sivia Capital.
